The article Atai Reports Q3 Financials and Business Update was originally published on Microdose. atai Life Sciences has the biggest product portfolio...
FDA denies marijuana petition 10 years after filing; MN gov: legalization to be among 1st bills signed in ’23; WI gov putting legal cannabis in budget...
SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported...
Clinical-stage biopharmaceutical company atai Life Sciences (Nasdaq: ATAI) reported financial results for the third quarter ending Sept. 30, providing...
Big Pharma feeling pressure to join forces with psychedelics firms to develop mental health treatments The post Can Psychedelics Solve Big Pharma’s Mental...
The Women in Psychedelics Network , a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing...
DelveInsight’s post-traumatic stress disorder pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies...
Source: Dr. Elemer Piros 10/27/2022 This firm, with eight treatment candidates for mental health disorders in development, boasts a catalyst-rich...
The article News You Might Have Missed: Oct 27th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article Atai Completes Enrollment of Phase 2a Trial for Depression was originally published on Microdose. atai Life Sciences has moved its most advanced...